Viewing Study NCT01740427


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT01740427
Status: COMPLETED
Last Update Posted: 2024-11-14
First Post: 2012-11-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02-22
Start Date Type: ACTUAL
Primary Completion Date: 2016-02-26
Primary Completion Date Type: ACTUAL
Completion Date: 2023-11-09
Completion Date Type: ACTUAL
First Submit Date: 2012-11-26
First Submit QC Date: None
Study First Post Date: 2012-12-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-10-21
Results First Submit QC Date: None
Results First Post Date: 2017-04-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-22
Last Update Post Date: 2024-11-14
Last Update Post Date Type: ACTUAL